과제정보
This research was supported by a grant funded by the Korean Society of Pain and Autonomic Disorders.
참고문헌
- International Association for the Study of Pain (IASP). IASP terminology [Internet]. Washington, D.C. (USA): IASP; c2017 [accessed 2019 Apr 1]. Available from: www.iasp-pain.org/terminology.
- Bradl M, Kanamori Y, Nakashima I, Misu T, Fujihara K, Lassmann H, et al. Pain in neuromyelitis optica--prevalence, pathogenesis and therapy. Nat Rev Neurol 2014;10:529-536. https://doi.org/10.1038/nrneurol.2014.129
- Hyun JW, Jang H, Yu J, Park NY, Kim SH, Huh SY, et al. Comparison of neuropathic pain in neuromyelitis optica spectrum disorder and multiple sclerosis. J Clin Neurol 2020;16:124-130. https://doi.org/10.3988/jcn.2020.16.1.124
- Watanabe M, Nakamura Y, Michalak Z, Isobe N, Barro C, Leppert D, et al. Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD. Neurology 2019;93:e1299-e1311. https://doi.org/10.1212/WNL.0000000000008160
- Uzawa A, Mori M, Arai K, Sato Y, Hayakawa S, Masuda S, et al. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler 2010;16:1443-1452. https://doi.org/10.1177/1352458510379247
- Sung JK, Choi JH, Jeong J, Kim WJ, Lee DJ, Lee SC, et al. Korean version of the painDETECT questionnaire: a study for cultural adaptation and validation. Pain Pract 2017;17:494-504. https://doi.org/10.1111/papr.12472
- Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 2015;85:177-189. https://doi.org/10.1212/WNL.0000000000001729
- Kim Y, Kim G, Kong BS, Lee JE, Oh YM, Hyun JW, et al. Large-scale in-house cell-based assay for evaluating the serostatus in patients with neuromyelitis optica spectrum disorder based on new diagnostic criteria. J Clin Neurol 2017;13:175-180. https://doi.org/10.3988/jcn.2017.13.2.175
- Freynhagen R, Tolle TR, Gockel U, Baron R. The painDETECT project-far more than a screening tool on neuropathic pain. Curr Med Res Opin 2016;32:1033-1057. https://doi.org/10.1185/03007995.2016.1157460
- Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-2112. https://doi.org/10.1016/S0140-6736(04)17551-X
- Hung AL, Lim M, Doshi TL. Targeting cytokines for treatment of neuropathic pain. Scand J Pain 2017;17:287-293. https://doi.org/10.1016/j.sjpain.2017.08.002
- Wei XH, Zang Y, Wu CY, Xu JT, Xin WJ, Liu XG. Peri-sciatic administration of recombinant rat TNF-alpha induces mechanical allodynia via upregulation of TNF-alpha in dorsal root ganglia and in spinal dorsal horn: the role of NF-kappa B pathway. Exp Neurol 2007;205:471-484. https://doi.org/10.1016/j.expneurol.2007.03.012
- Zanella JM, Burright EN, Hildebrand K, Hobot C, Cox M, Christoferson L, et al. Effect of etanercept, a tumor necrosis factor-alpha inhibitor, on neuropathic pain in the rat chronic constriction injury model. Spine (Phila Pa 1976) 2008;33:227-234. https://doi.org/10.1097/BRS.0b013e318162340a
- Wang K, Bao JP, Yang S, Hong X, Liu L, Xie XH, et al. A cohort study comparing the serum levels of pro- or anti-inflammatory cytokines in patients with lumbar radicular pain and healthy subjects. Eur Spine J 2016;25:1428-1434. https://doi.org/10.1007/s00586-015-4349-4
- Zu B, Pan H, Zhang XJ, Yin ZS. Serum levels of the inflammatory cytokines in patients with lumbar radicular pain due to disc herniation. Asian Spine J 2016;10:843-849. https://doi.org/10.4184/asj.2016.10.5.843
- US Food and Drug. Information on Tumor Necrosis Factor (TNF) Blockers (marketed as Remicade, Enbrel, Humira, Cimzia, and Simponi) [Internet]. Washington, D.C., USA: US Food and Drug; c2021 [accessed 2021 Feb 25]. Available from: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/information-tumor-necrosis-factor-tnf-blockers-marketed-remicade-enbrel-humira-cimzia-and-simponi.
- Kemanetzoglou E, Andreadou E. CNS demyelination with TNF-α blockers. Curr Neurol Neurosci Rep 2017;17:36. https://doi.org/10.1007/s11910-017-0742-1
- Ramer MS, Murphy PG, Richardson PM, Bisby MA. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain 1998;78:115-121. https://doi.org/10.1016/S0304-3959(98)00121-3
- Guptarak J, Wanchoo S, Durham-Lee J, Wu Y, Zivadinovic D, Paulucci-Holthauzen A, et al. Inhibition of IL-6 signaling: a novel therapeutic approach to treating spinal cord injury pain. Pain 2013;154:1115-1128. https://doi.org/10.1016/j.pain.2013.03.026
- Araki M, Matsuoka T, Miyamoto K, Kusunoki S, Okamoto T, Murata M, et al. Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: a pilot study. Neurology 2014;82:1302-1306. https://doi.org/10.1212/WNL.0000000000000317
- Kim CF, Moalem-Taylor G. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. J Pain 2011;12:370-383. https://doi.org/10.1016/j.jpain.2010.08.003
- Day YJ, Liou JT, Lee CM, Lin YC, Mao CC, Chou AH, et al. Lack of interleukin-17 leads to a modulated micro-environment and amelioration of mechanical hypersensitivity after peripheral nerve injury in mice. Pain 2014;155:1293-1302. https://doi.org/10.1016/j.pain.2014.04.004
- Shao Q, Li Y, Wang Q, Zhao J. IL-10 and IL-1β mediate neuropathic-pain like behavior in the ventrolateral orbital cortex. Neurochem Res 2015;40:733-739. https://doi.org/10.1007/s11064-015-1521-5